ID: ALA3732585

Max Phase: Preclinical

Molecular Formula: C14H9N3S2

Molecular Weight: 283.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1csc(-c2cn3c(-c4cccs4)cnc3cn2)c1

Standard InChI:  InChI=1S/C14H9N3S2/c1-3-12(18-5-1)10-9-17-11(13-4-2-6-19-13)7-16-14(17)8-15-10/h1-9H

Standard InChI Key:  FTRPZMMJTUZSDQ-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-TC6 562 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 283.38Molecular Weight (Monoisotopic): 283.0238AlogP: 4.19#Rotatable Bonds: 2
Polar Surface Area: 30.19Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.49CX LogP: 2.70CX LogD: 2.70
Aromatic Rings: 4Heavy Atoms: 19QED Weighted: 0.55Np Likeness Score: -1.65

References

1.  (2014)  Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5, 

Source